首页 | 本学科首页   官方微博 | 高级检索  
检索        

短发卡RNA对人胃癌细胞STAT3基因的沉默作用
引用本文:童强,舒晓刚,卢晓明,黎维勇,陶凯雄,陈道达,王国斌.短发卡RNA对人胃癌细胞STAT3基因的沉默作用[J].中国普通外科杂志,2008,17(5):16-465.
作者姓名:童强  舒晓刚  卢晓明  黎维勇  陶凯雄  陈道达  王国斌
作者单位:1. 华中科技大学同济医学院附属协和医院,胃肠外科,湖北,武汉,430022
2. 华中科技大学同济医学院附属协和医院,药剂科,湖北,武汉,430022
3. 华中科技大学同济医学院附属协和医院,腔镜外科,湖北,武汉,430022
4. 华中科技大学同济医学院附属协和医院,胃肠外科,湖北,武汉,430022;华中科技大学同济医学院附属协和医院,腔镜外科,湖北,武汉,430022
摘    要:目的:探讨STAT3基因小发夹RNA(shRNA)表达质粒对胃癌MKN-45细胞STAT3基因的干扰作用。方法:根据STAT3 mRNA 编码序列,设计RNA干扰靶点,构建STAT3基因的特异性小RNA干扰质粒(psiRNA-H1/STAT3),使用脂质体转染人胃癌细胞系(MKN-45细胞)。实验分为对照(A)组,psiRNA-H1转染(B)组和psiRNA-H1/STAT3转染(C)组。通过RT-PCR和Western Blot检测STAT3特异性小RNA干扰基因对胃癌细胞STAT3基因mRNA和蛋白表达的影响。结果:psiRNA-H1/STAT3经限制性酶切及部分序列分析证明基因插入正确,并经测序证实。将其成功转染MKN-45细胞后,该细胞的STAT3 mRNA和蛋白表达均明显下降(P<0.05)。 结论:将成功构建的针对STAT3基因的shRNA表达载体转染MKN-45细胞,能有效抑制该细胞的STAT3 mRNA和蛋白表达,为STAT3基因靶向治疗提供一定的实验依据。

关 键 词:胃肿瘤  STAT3  转录因子  RNA干扰  基因表达  短发卡  人胃癌细胞系  基因靶向治疗  作用  gastric  cancer  cells  gene  shRNA  mediated  plasmid  表达载体  测序  基因插入  分析证明  部分序列  限制性酶切  结果  影响  蛋白表达  基因对  检测
文章编号:1005-6947(2008)05-0462-04
收稿时间:1900/1/1 0:00:00
修稿时间:2008年1月10日

Silence effect of plasmid mediated shRNA on STAT3 gene in gastric cancer cells
TONG Qiang,SHU Xiaogang,LU Xiaoming,LI Weiyong,TAO Kaixiong,CHEN Daod,WANG Guobin,.Silence effect of plasmid mediated shRNA on STAT3 gene in gastric cancer cells[J].Chinese Journal of General Surgery,2008,17(5):16-465.
Authors:TONG Qiang  SHU Xiaogang  LU Xiaoming  LI Weiyong  TAO Kaixiong  CHEN Daod  WANG Guobin  
Institution:(1.Department of Gastrointestinal Surgery 2.Pharmaceutical Preparation Section 3.Department of Laparoscope Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China)
Abstract:Abstract:Objective:To study the interfering effect of short hairpin RNA(shRNA) expressing plasmid vectors on STAT3 gene expression of human gastric carcinoma cells.Methods :Specific shRNA plasmids to STAT3 were constructed, and then transfected into MKN-45 cells by lipofectamine methods. Semi-quantitative RT-PCR and Western blotting were used to detect the expression of STAT3 mRNA and protein respectively. Cells were divided into three groups: control group (A group), psiRNA-H1 group (negative group, B group) and psiRNA-H1/STAT3 group (C group).Results:The synthesized strands of oligonucleotide contained correct and complete sequence of the shRNA, and the STAT3 specific shRNA was inserted into eukaryotic expression.Compared with the A and B group cells, semi-quantitative RT-PCR and Western blotting showed the expression of STAT3 mRNA and protein was down-regulated in the C group (P<0.05).Conclusions:The recombinant plasmid psiRNA-H1/STAT3 shRNA has been constructed successfully, and it can specificly inhibit not only the expression of STAT3 mRNA, but also the protein expression in gastric carcinoma cells in vitro.It provides certain experimental basis for STAT3 gene target therapy.
Keywords:
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号